Rejuvae Aesthetics & Wellness
Rejuvae Aesthetics & Wellness · 7601 Madison Street · Forest Park, IL 60130
5.0· 64 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Rejuvae Aesthetics & Wellness is a medical spa in Forest Park, Illinois, led by Kimberly Anderegg, APRN, whom its website describes as a nurse practitioner with more than 25 years in healthcare. The site describes personalized, natural-looking aesthetic treatments and a medical weight loss program that combines evidence-based treatments with ongoing support, beginning with a one-on-one consultation. The listing also includes hormone care. Google shows a 5.0-star rating across 64 reviews dating back to 2022, with 21 in the past year. Reviewers most often mention results and the team's knowledge. The site doesn't name specific weight-management medications, so ask which options it currently offers.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-16. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 64 Google reviews. Of the 64 reviews we analyzed, 64 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Weight-loss results18 reviews
- Knowledgeable, professional providers17 reviews
- Friendly, helpful staff12 reviews
- Feeling listened to4 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Kristen S.★★★★★2026-09-16Kristal & Kim are amazing! When getting treatments like these, I often worry I’ll be pulled into an upsell or try to get convinced of something I don’t really want to do, but my experience here is totally the opposite. They both really listen to what you’re trying to achieve with your skin & make sure you feel comfortable & heard the entire time. I recommend them to anyone!
Kelly B.★★★★★2026-09-09I found my favorite Botox person! Kim really takes the time to understand your skin and what you’d like to accomplish. I’ve always been very pleased with the outcomes each time I’ve been to see her. Highly recommend Rejuvate and I’ll continue to recommend her to my friends and family for her services.
Angie E.★★★★★2026-09-04I came to Rejuvae after experiencing an issue caused by a procedure performed at another clinic. Kimberly and Kristal were incredibly kind and made me feel calm, reassured, and well cared for while helping me with the problem. I highly recommend them for their experience, professionalism, and exceptional care. I will definitely be returning!
Meredith M.★★★★★2026-09-02Kimberly is exceptional. She takes great care and detail with her clients and provides no nonsense advice and guidance on treatments. There are so many options in the area and I’d recommend Kimberly 10/10 times.
Jackie S.★★★★★2026-08-26Kristal recommended i did 3 sessions of microneedling and fell in love with the results! My skin is glowing and can’t wait to come back!!!!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs